{"parse":{"title":"Northern epilepsy syndrome","pageid":22914405,"revid":859987453,"text":{"*":"<div class=\"mw-parser-output\"><table class=\"infobox\" style=\"width:22em\"><tbody><tr><th colspan=\"2\" style=\"text-align:center;font-size:125%;font-weight:bold;background:#ccc\">Northern epilepsy syndrome</th></tr><tr><th scope=\"row\">Synonyms</th><td>\nNeuronal ceroid lipofuscinosis, Northern epilepsy variant</td></tr><tr><td colspan=\"2\" style=\"text-align:center\">\n<a href=\"/wiki/File:Autosomal_recessive_-_en.svg\" class=\"image\"><img alt=\"Autosomal recessive - en.svg\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/f/f1/Autosomal_recessive_-_en.svg/300px-Autosomal_recessive_-_en.svg.png\" width=\"300\" height=\"533\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/f/f1/Autosomal_recessive_-_en.svg/450px-Autosomal_recessive_-_en.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/f/f1/Autosomal_recessive_-_en.svg/600px-Autosomal_recessive_-_en.svg.png 2x\" data-file-width=\"744\" data-file-height=\"1323\" /></a></td></tr><tr><td colspan=\"2\" style=\"text-align:center\">\nThis condition is inherited in an autosomal recessive manner</td></tr></tbody></table>\n<p><b>Northern epilepsy syndrome</b> or <b>progressive epilepsy with mental retardation</b> (<b>EPMR</b>) is a subtype of <a href=\"/wiki/Neuronal_ceroid_lipofuscinosis\" title=\"Neuronal ceroid lipofuscinosis\">neuronal ceroid lipofuscinosis</a> and a <a href=\"/wiki/Rare_disease\" title=\"Rare disease\">rare disease</a> that is regarded as a <a href=\"/wiki/Finnish_heritage_disease\" title=\"Finnish heritage disease\">Finnish heritage disease</a>.  Unlike most Finnish heritage diseases, this syndrome has been reported only in <a href=\"/wiki/Finland\" title=\"Finland\">Finland</a>.<sup id=\"cite_ref-1\" class=\"reference\"><a href=\"#cite_note-1\">&#91;1&#93;</a></sup>\nThe disease is characterized by seizures in early childhood that progressively get worse until after puberty. Once the onset of seizures occurs, mental degradation is seen. This continues into adulthood even after seizure frequency has decreased. The cause of the disease is a missense mutation in chromosome 8. The creation of a new protein occurs and the lipid content of the brain is altered because of it.  The ratio of the mutation carriers is 1:135. There is nothing that has been found to stop the progression of the disease, but symptomatic approaches, such as the use of <a href=\"/wiki/Benzodiazepine\" title=\"Benzodiazepine\">benzodiazepines</a>, have helped control seizures.<sup id=\"cite_ref-Prevention_Genetics_2-0\" class=\"reference\"><a href=\"#cite_note-Prevention_Genetics-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-Genetics_Home_Reference_3-0\" class=\"reference\"><a href=\"#cite_note-Genetics_Home_Reference-3\">&#91;3&#93;</a></sup><sup id=\"cite_ref-New_Member_4-0\" class=\"reference\"><a href=\"#cite_note-New_Member-4\">&#91;4&#93;</a></sup>\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Characteristics\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Characteristics</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-2\"><a href=\"#Early_childhood\"><span class=\"tocnumber\">1.1</span> <span class=\"toctext\">Early childhood</span></a></li>\n<li class=\"toclevel-2 tocsection-3\"><a href=\"#Adolescence\"><span class=\"tocnumber\">1.2</span> <span class=\"toctext\">Adolescence</span></a></li>\n<li class=\"toclevel-2 tocsection-4\"><a href=\"#Adulthood\"><span class=\"tocnumber\">1.3</span> <span class=\"toctext\">Adulthood</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-5\"><a href=\"#Genetic_causes\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Genetic causes</span></a></li>\n<li class=\"toclevel-1 tocsection-6\"><a href=\"#Pathophysiology\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Pathophysiology</span></a></li>\n<li class=\"toclevel-1 tocsection-7\"><a href=\"#Diagnosis\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">Diagnosis</span></a></li>\n<li class=\"toclevel-1 tocsection-8\"><a href=\"#Treatment\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">Treatment</span></a></li>\n<li class=\"toclevel-1 tocsection-9\"><a href=\"#Prognosis\"><span class=\"tocnumber\">6</span> <span class=\"toctext\">Prognosis</span></a></li>\n<li class=\"toclevel-1 tocsection-10\"><a href=\"#History\"><span class=\"tocnumber\">7</span> <span class=\"toctext\">History</span></a></li>\n<li class=\"toclevel-1 tocsection-11\"><a href=\"#See_also\"><span class=\"tocnumber\">8</span> <span class=\"toctext\">See also</span></a></li>\n<li class=\"toclevel-1 tocsection-12\"><a href=\"#References\"><span class=\"tocnumber\">9</span> <span class=\"toctext\">References</span></a></li>\n<li class=\"toclevel-1 tocsection-13\"><a href=\"#External_links\"><span class=\"tocnumber\">10</span> <span class=\"toctext\">External links</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"Characteristics\">Characteristics</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Northern_epilepsy_syndrome&amp;action=edit&amp;section=1\" title=\"Edit section: Characteristics\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<h3><span class=\"mw-headline\" id=\"Early_childhood\">Early childhood</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Northern_epilepsy_syndrome&amp;action=edit&amp;section=2\" title=\"Edit section: Early childhood\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Northern Epilepsy Syndrome causes recurrent seizures between the ages of five to ten. These seizures, that may last up to 15 minutes, can be classified mostly as <a href=\"/wiki/Tonic%E2%80%93clonic_seizure\" class=\"mw-redirect\" title=\"Tonic\u2013clonic seizure\">tonic-clonic</a>, but <a href=\"/wiki/Partial_seizure\" class=\"mw-redirect\" title=\"Partial seizure\">partial seizures</a> could also occur. The seizures commonly involve muscle rigidity, convulsions, and loss of consciousness. Generally, the recurrence is one to two times per month.\nIn the years following the onset of seizures, a noticeable decrease in intellectual capacity is observed.<sup id=\"cite_ref-Genetics_Home_Reference_3-1\" class=\"reference\"><a href=\"#cite_note-Genetics_Home_Reference-3\">&#91;3&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Adolescence\">Adolescence</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Northern_epilepsy_syndrome&amp;action=edit&amp;section=3\" title=\"Edit section: Adolescence\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>During puberty, seizure frequency increases to one to two times per week.<sup id=\"cite_ref-New_Member_4-1\" class=\"reference\"><a href=\"#cite_note-New_Member-4\">&#91;4&#93;</a></sup>  Mental function has a rapid decline, as observed by a lack of coordination, failure to complete education, and fine motor activities.<sup id=\"cite_ref-Genetics_Home_Reference_3-2\" class=\"reference\"><a href=\"#cite_note-Genetics_Home_Reference-3\">&#91;3&#93;</a></sup>  In rare cases, some suffered from loss of vision.<sup id=\"cite_ref-Prevention_Genetics_2-1\" class=\"reference\"><a href=\"#cite_note-Prevention_Genetics-2\">&#91;2&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Adulthood\">Adulthood</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Northern_epilepsy_syndrome&amp;action=edit&amp;section=4\" title=\"Edit section: Adulthood\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Seizure frequency is reduced to four to six seizures per year.<sup id=\"cite_ref-Genetics_Home_Reference_3-3\" class=\"reference\"><a href=\"#cite_note-Genetics_Home_Reference-3\">&#91;3&#93;</a></sup> By this time, they are mentally and physically incapable to live without assistance due to the total mental degradation. Life expectancy is at least 50 years of age, which is shorter than the average worldwide age of 70.<sup id=\"cite_ref-New_Member_4-2\" class=\"reference\"><a href=\"#cite_note-New_Member-4\">&#91;4&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Genetic_causes\">Genetic causes</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Northern_epilepsy_syndrome&amp;action=edit&amp;section=5\" title=\"Edit section: Genetic causes\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Northern epilepsy syndrome is caused by an inherited recessive autosomal mutation in the telomeric region of the short arm of <a href=\"/wiki/Chromosome_8\" title=\"Chromosome 8\">chromosome 8</a>. There are at least ten mutations within the chromosome and the most common <a href=\"/wiki/Missense_mutation\" title=\"Missense mutation\">missense mutation</a> occurs at <a href=\"/wiki/Codon\" class=\"mw-redirect\" title=\"Codon\">codon</a> 24, where a <a href=\"/wiki/Glycine\" title=\"Glycine\">glycine</a> takes the place of an <a href=\"/wiki/Arginine\" title=\"Arginine\">arginine</a>. This primary mutation can also be paired with a missense at codon 237, where an arginine takes the place of a glycine. When the two mutations interact, a lengthened progression of the disease is observed.<sup id=\"cite_ref-Molecular_genetics_5-0\" class=\"reference\"><a href=\"#cite_note-Molecular_genetics-5\">&#91;5&#93;</a></sup>  The primary mutation (Arg24Gly) creates the protein <a href=\"/wiki/CLN8\" title=\"CLN8\">CLN8</a>. One in every 135 of Finnish descent were reported to be a carrier of the mutation.<sup id=\"cite_ref-Prevention_Genetics_2-2\" class=\"reference\"><a href=\"#cite_note-Prevention_Genetics-2\">&#91;2&#93;</a></sup> The difference between 1-CLN8 and 2-CLN8 is the amount of mutations and the mutation's location in the chromosome.<sup id=\"cite_ref-Prevention_Genetics_2-3\" class=\"reference\"><a href=\"#cite_note-Prevention_Genetics-2\">&#91;2&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Pathophysiology\">Pathophysiology</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Northern_epilepsy_syndrome&amp;action=edit&amp;section=6\" title=\"Edit section: Pathophysiology\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>An accumulation of transmembrane protein is seen in the brain tissue of northern epilepsy patients. This protein is a 286 amino acid transmembrane protein that has not been identified before, meaning that it is unique to Northern Epilepsy Syndrome.<sup id=\"cite_ref-New_Member_4-3\" class=\"reference\"><a href=\"#cite_note-New_Member-4\">&#91;4&#93;</a></sup> <a href=\"/wiki/CLN8\" title=\"CLN8\">CLN8</a> has been linked to the accumulation of <a href=\"/wiki/ATP_synthase_subunit_C\" title=\"ATP synthase subunit C\">subunit c</a> of mitochondrial ATP synthase and a small amount of sphingolipid activator proteins in the neurons. <a href=\"/wiki/%CE%92_amyloid\" class=\"mw-redirect\" title=\"\u0392 amyloid\">\u03b2-amyloid</a>, a peptide involved in Alzheimer's disease, is also seen in this protein accumulation.<sup id=\"cite_ref-New_Member_4-4\" class=\"reference\"><a href=\"#cite_note-New_Member-4\">&#91;4&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Diagnosis\">Diagnosis</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Northern_epilepsy_syndrome&amp;action=edit&amp;section=7\" title=\"Edit section: Diagnosis\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>A patient\u2019s DNA is sequenced from a blood sample with the use of the ABI Big Dye Terminator v.3.0 kit. Since this is a genetic disease, the basis of diagnosis lies in identifying genetic mutations or chromosomal abnormalities. The <a href=\"/wiki/DNA_sequence\" class=\"mw-redirect\" title=\"DNA sequence\">DNA sequence</a> can be run with CLN8 <a href=\"/wiki/Sanger_sequencing\" title=\"Sanger sequencing\">Sanger Sequencing</a> or CLN8 Targeted Familial Mutations whether its single, double, or triple <a href=\"/wiki/Exome_sequencing\" title=\"Exome sequencing\">Exon Sequencing</a>.<sup id=\"cite_ref-Prevention_Genetics_2-4\" class=\"reference\"><a href=\"#cite_note-Prevention_Genetics-2\">&#91;2&#93;</a></sup> Also, preliminary evidence of the disease can be detected by means of <a href=\"/wiki/MRI\" class=\"mw-redirect\" title=\"MRI\">MRI</a> and <a href=\"/wiki/EEG\" class=\"mw-redirect\" title=\"EEG\">EEG</a>.<sup id=\"cite_ref-New_Member_4-5\" class=\"reference\"><a href=\"#cite_note-New_Member-4\">&#91;4&#93;</a></sup> These tests identify lipid content of the brain and any anomaly from the norm may be linked to Northern epilepsy.\n</p>\n<h2><span class=\"mw-headline\" id=\"Treatment\">Treatment</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Northern_epilepsy_syndrome&amp;action=edit&amp;section=8\" title=\"Edit section: Treatment\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Current available treatment is limited to treating the symptoms, not the cause. Seizure frequency can be regulated by the use of drugs such as <a href=\"/wiki/Clonazepam\" title=\"Clonazepam\">Clonazepam</a> (or other <a href=\"/wiki/Benzodiazepine\" title=\"Benzodiazepine\">benzodiazepines</a>)  and <a href=\"/wiki/Sodium_valproate\" class=\"mw-redirect\" title=\"Sodium valproate\">Sodium Valproate</a>. Clonazepam functions by increasing <a href=\"/wiki/GABA\" class=\"mw-redirect\" title=\"GABA\">GABA</a> activity at the <a href=\"/wiki/GABAA_receptor\" title=\"GABAA receptor\">GABA<sub>A</sub> receptor</a>. GABA is an inhibitory neurotransmitter and therefore, its increased activity hyperpolarizes cells. Clonazepam has been effective in minimising seizure activity, especially during puberty.<sup id=\"cite_ref-New_Member_4-6\" class=\"reference\"><a href=\"#cite_note-New_Member-4\">&#91;4&#93;</a></sup> Sodium valproate prevents the depolarization of the cell by blocking sodium ion channels and inhibitory GABA enzymes. Both of these <a href=\"/wiki/Anticonvulsant\" title=\"Anticonvulsant\">anticonvulsants</a> lead to depression of the central nervous system.\n</p>\n<h2><span class=\"mw-headline\" id=\"Prognosis\">Prognosis</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Northern_epilepsy_syndrome&amp;action=edit&amp;section=9\" title=\"Edit section: Prognosis\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Life expectancy is only moderately affected by NE because the rate of disease progression is slow. Patients usually survive past 40-50 years of age.<sup id=\"cite_ref-6\" class=\"reference\"><a href=\"#cite_note-6\">&#91;6&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"History\">History</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Northern_epilepsy_syndrome&amp;action=edit&amp;section=10\" title=\"Edit section: History\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Northern epilepsy originated in Northern Finland and it still appears to only affect individuals of Finnish ancestry. 1 in 10,000 individuals who live or are from the region of Kainuu in northern Finland have the condition.\nNorthern epilepsy was not initially recognized as a <a href=\"/wiki/Neuronal_ceroid_lipofuscinosis\" title=\"Neuronal ceroid lipofuscinosis\">Neuronal ceroid lipofuscinosis</a> (NCL). In 1999, it was found to be the first disease identified caused by mutations in the <a href=\"/wiki/CLN8\" title=\"CLN8\">CLN8</a> gene. The disease is now known as the mildest form of NCL.<sup id=\"cite_ref-7\" class=\"reference\"><a href=\"#cite_note-7\">&#91;7&#93;</a></sup> There are two forms of this mutated gene: 1-CLN8 and 2-CLN8. 1-CLN8 is known as Northern Epilepsy Syndrome, while 2-CLN8 is primarily from Turkish descent.<sup id=\"cite_ref-Prevention_Genetics_2-5\" class=\"reference\"><a href=\"#cite_note-Prevention_Genetics-2\">&#91;2&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"See_also\">See also</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Northern_epilepsy_syndrome&amp;action=edit&amp;section=11\" title=\"Edit section: See also\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a href=\"/wiki/Epilepsy\" title=\"Epilepsy\">Epilepsy</a></li>\n<li><a href=\"/wiki/Neuronal_ceroid_lipofuscinosis\" title=\"Neuronal ceroid lipofuscinosis\">Neuronal ceroid lipofuscinosis</a></li>\n<li><a href=\"/wiki/CLN8\" title=\"CLN8\">CLN8</a></li></ul>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Northern_epilepsy_syndrome&amp;action=edit&amp;section=12\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist\" style=\"list-style-type: decimal;\">\n<div class=\"mw-references-wrap\"><ol class=\"references\">\n<li id=\"cite_note-1\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-1\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">Krystyna E. Wi\u015bniewski; Nanbert Zhong; Jeffrey C. Hall (2001). <i>Batten disease: diagnosis, treatment, and research</i>. Academic Press. p.&#160;243. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/0-12-017645-9\" title=\"Special:BookSources/0-12-017645-9\">0-12-017645-9</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Batten+disease%3A+diagnosis%2C+treatment%2C+and+research&amp;rft.pages=243&amp;rft.pub=Academic+Press&amp;rft.date=2001&amp;rft.isbn=0-12-017645-9&amp;rft.au=Krystyna+E.+Wi%C5%9Bniewski&amp;rft.au=Nanbert+Zhong&amp;rft.au=Jeffrey+C.+Hall&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANorthern+epilepsy+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span> page 125</span>\n</li>\n<li id=\"cite_note-Prevention_Genetics-2\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Prevention_Genetics_2-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Prevention_Genetics_2-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Prevention_Genetics_2-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-Prevention_Genetics_2-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-Prevention_Genetics_2-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-Prevention_Genetics_2-5\"><sup><i><b>f</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://preventiongenetics.com/print-test?id=1804\">\"NEURONAL CEROID LIPOFUSCINOSIS 8 VIA THE CLN8 GENE\"</a>. Prevention Genetics<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">23 March</span> 2014</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=NEURONAL+CEROID+LIPOFUSCINOSIS+8+VIA+THE+CLN8+GENE&amp;rft.pub=Prevention+Genetics&amp;rft_id=http%3A%2F%2Fpreventiongenetics.com%2Fprint-test%3Fid%3D1804&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANorthern+epilepsy+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Genetics_Home_Reference-3\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Genetics_Home_Reference_3-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Genetics_Home_Reference_3-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Genetics_Home_Reference_3-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-Genetics_Home_Reference_3-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://ghr.nlm.nih.gov/condition/northern-epilepsy\">\"Northern epilepsy\"</a>. U.S. National Library of Medicine<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">23 March</span> 2014</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Northern+epilepsy&amp;rft.pub=U.S.+National+Library+of+Medicine&amp;rft_id=http%3A%2F%2Fghr.nlm.nih.gov%2Fcondition%2Fnorthern-epilepsy&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANorthern+epilepsy+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-New_Member-4\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-New_Member_4-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-New_Member_4-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-New_Member_4-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-New_Member_4-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-New_Member_4-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-New_Member_4-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-New_Member_4-6\"><sup><i><b>g</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Ranta, S; Lehesjoki AE (2000). <a rel=\"nofollow\" class=\"external text\" href=\"https://link.springer.com/article/10.1007/s100720070039\">\"Northern epilepsy, a new member of the NCL family\"</a>. <i>Neurological Sciences</i>. <b>21</b> (1 Supplement): S43\u2013S47. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/s100720070039\">10.1007/s100720070039</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/11073227\">11073227</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">23 March</span> 2014</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurological+Sciences&amp;rft.atitle=Northern+epilepsy%2C+a+new+member+of+the+NCL+family.&amp;rft.volume=21&amp;rft.issue=1+Supplement&amp;rft.pages=S43-S47&amp;rft.date=2000&amp;rft_id=info%3Adoi%2F10.1007%2Fs100720070039&amp;rft_id=info%3Apmid%2F11073227&amp;rft.aulast=Ranta&amp;rft.aufirst=S&amp;rft.au=Lehesjoki+AE&amp;rft_id=https%3A%2F%2Flink.springer.com%2Farticle%2F10.1007%2Fs100720070039&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANorthern+epilepsy+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Molecular_genetics-5\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Molecular_genetics_5-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Siintola, E; Lehesjoki AE; Mole SE (2006). \"Molecular genetics of the NCLs -- status and perspectives\". <i>Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease</i>. <b>1762</b> (10): 857\u2013864. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.bbadis.2006.05.006\">10.1016/j.bbadis.2006.05.006</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/16828266\">16828266</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Biochimica+et+Biophysica+Acta+%28BBA%29+-+Molecular+Basis+of+Disease&amp;rft.atitle=Molecular+genetics+of+the+NCLs+--+status+and+perspectives.&amp;rft.volume=1762&amp;rft.issue=10&amp;rft.pages=857-864&amp;rft.date=2006&amp;rft_id=info%3Adoi%2F10.1016%2Fj.bbadis.2006.05.006&amp;rft_id=info%3Apmid%2F16828266&amp;rft.aulast=Siintola&amp;rft.aufirst=E&amp;rft.au=Lehesjoki+AE&amp;rft.au=Mole+SE&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANorthern+epilepsy+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-6\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-6\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Herva, Riitta; Tyynel\u00e4, Jaana; Hirvasniemi, Aune; Syrj\u00e4kallio-Ylitalo, Marja; Haltia, Matti (2000-04-01). <a rel=\"nofollow\" class=\"external text\" href=\"http://onlinelibrary.wiley.com/doi/10.1111/j.1750-3639.2000.tb00255.x/abstract\">\"Northern Epilepsy: A Novel Form of Neuronal Ceroid-Lipofuscinosis\"</a>. <i>Brain Pathology</i>. <b>10</b> (2): 215\u2013222. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1111/j.1750-3639.2000.tb00255.x\">10.1111/j.1750-3639.2000.tb00255.x</a>. <a href=\"/wiki/International_Standard_Serial_Number\" title=\"International Standard Serial Number\">ISSN</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/issn/1750-3639\">1750-3639</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Brain+Pathology&amp;rft.atitle=Northern+Epilepsy%3A+A+Novel+Form+of+Neuronal+Ceroid-Lipofuscinosis&amp;rft.volume=10&amp;rft.issue=2&amp;rft.pages=215-222&amp;rft.date=2000-04-01&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1750-3639.2000.tb00255.x&amp;rft.issn=1750-3639&amp;rft.aulast=Herva&amp;rft.aufirst=Riitta&amp;rft.au=Tyynel%C3%A4%2C+Jaana&amp;rft.au=Hirvasniemi%2C+Aune&amp;rft.au=Syrj%C3%A4kallio-Ylitalo%2C+Marja&amp;rft.au=Haltia%2C+Matti&amp;rft_id=http%3A%2F%2Fonlinelibrary.wiley.com%2Fdoi%2F10.1111%2Fj.1750-3639.2000.tb00255.x%2Fabstract&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANorthern+epilepsy+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-7\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-7\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Warrier, V; Vieirab M; Mole SE (2013). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.sciencedirect.com/science/article/pii/S0925443913000914#\">\"Genetic basis and phenotypic correlations of the neuronal ceroid lipofusinoses\"</a>. <i>Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease</i>. <b>1832</b> (11): 1827\u20131830. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.bbadis.2013.03.017\">10.1016/j.bbadis.2013.03.017</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23542453\">23542453</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">23 March</span> 2014</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Biochimica+et+Biophysica+Acta+%28BBA%29+-+Molecular+Basis+of+Disease&amp;rft.atitle=Genetic+basis+and+phenotypic+correlations+of+the+neuronal+ceroid+lipofusinoses&amp;rft.volume=1832&amp;rft.issue=11&amp;rft.pages=1827-1830&amp;rft.date=2013&amp;rft_id=info%3Adoi%2F10.1016%2Fj.bbadis.2013.03.017&amp;rft_id=info%3Apmid%2F23542453&amp;rft.aulast=Warrier&amp;rft.aufirst=V&amp;rft.au=Vieirab+M&amp;rft.au=Mole+SE&amp;rft_id=http%3A%2F%2Fwww.sciencedirect.com%2Fscience%2Farticle%2Fpii%2FS0925443913000914%23&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANorthern+epilepsy+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n</ol></div></div>\n<h2><span class=\"mw-headline\" id=\"External_links\">External links</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Northern_epilepsy_syndrome&amp;action=edit&amp;section=13\" title=\"Edit section: External links\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<table class=\"infobox\" style=\"width:22em;width:100%; margin:0 0 0.5em 0;\"><tbody><tr><th scope=\"row\">Classification</th><td style=\"text-align:left;\">\n<div style=\"position:relative; float:right; font-size:0.8em;\"><a href=\"https://www.wikidata.org/wiki/Q7059204\" class=\"extiw\" title=\"d:Q7059204\">D</a></div><div class=\"hlist hlist-separated\" style=\"text-align:left;\"><ul><li><b><a href=\"/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems\" title=\"International Statistical Classification of Diseases and Related Health Problems\">ICD</a>-<a href=\"/wiki/ICD-10\" title=\"ICD-10\">10</a></b>: E75.4</li><li><b><a href=\"/wiki/OMIM\" class=\"mw-redirect\" title=\"OMIM\">OMIM</a></b>: <a rel=\"nofollow\" class=\"external text\" href=\"https://omim.org/entry/610003\">610003</a></li><li><b><a href=\"/wiki/Diseases_Database\" title=\"Diseases Database\">DiseasesDB</a></b>: <a rel=\"nofollow\" class=\"external text\" href=\"http://www.diseasesdatabase.com/ddb33514.htm\">33514</a></li></ul></div></td></tr><tr><th scope=\"row\">External resources</th><td style=\"text-align:left;\">\n<div class=\"hlist hlist-separated\" style=\"text-align:left;\"><ul><li><b><a href=\"/wiki/Orphanet\" title=\"Orphanet\">Orphanet</a></b>: <a rel=\"nofollow\" class=\"external text\" href=\"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=1947\">1947</a></li></ul></div></td></tr></tbody></table>\n\n<!-- \nNewPP limit report\nParsed by mw2192\nCached time: 20180919132402\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.204 seconds\nReal time usage: 0.255 seconds\nPreprocessor visited node count: 1039/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 19902/2097152 bytes\nTemplate argument size: 590/2097152 bytes\nHighest expansion depth: 9/40\nExpensive parser function count: 0/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 12282/5000000 bytes\nNumber of Wikibase entities loaded: 1/400\nLua time usage: 0.101/10.000 seconds\nLua memory usage: 4.42 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  216.837      1 -total\n 46.31%  100.412      2 Template:Infobox\n 39.60%   85.869      1 Template:Infobox_medical_condition_(new)\n 38.56%   83.614      1 Template:Reflist\n 16.38%   35.510      1 Template:Medical_resources\n 15.57%   33.756      1 Template:Cite_book\n 10.55%   22.874      4 Template:Cite_journal\n  6.31%   13.680      2 Template:Hlist\n  4.56%    9.889      2 Template:Cite_web\n  4.16%    9.030      4 Template:Main_other\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:22914405-0!canonical and timestamp 20180919132402 and revision id 859987453\n -->\n</div>"},"langlinks":[{"lang":"pl","url":"https://pl.wikipedia.org/wiki/Padaczka_p%C3%B3%C5%82nocna","langname":"Polish","autonym":"polski","*":"Padaczka p\u00f3\u0142nocna"},{"lang":"fi","url":"https://fi.wikipedia.org/wiki/Pohjoinen_epilepsia","langname":"Finnish","autonym":"suomi","*":"Pohjoinen epilepsia"}],"categories":[{"sortkey":"","hidden":"","*":"Infobox_medical_condition_(new)"},{"sortkey":"","*":"Rare_syndromes"},{"sortkey":"","*":"Health_in_Finland"}],"links":[{"ns":0,"exists":"","*":"ATP synthase subunit C"},{"ns":0,"exists":"","*":"Anticonvulsant"},{"ns":0,"exists":"","*":"Arginine"},{"ns":0,"exists":"","*":"Benzodiazepine"},{"ns":0,"exists":"","*":"CLN8"},{"ns":0,"exists":"","*":"Chromosome 8"},{"ns":0,"exists":"","*":"Clonazepam"},{"ns":0,"exists":"","*":"Codon"},{"ns":0,"exists":"","*":"DNA sequence"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Diseases Database"},{"ns":0,"exists":"","*":"EEG"},{"ns":0,"exists":"","*":"Epilepsy"},{"ns":0,"exists":"","*":"Exome sequencing"},{"ns":0,"exists":"","*":"Finland"},{"ns":0,"exists":"","*":"Finnish heritage disease"},{"ns":0,"exists":"","*":"GABA"},{"ns":0,"exists":"","*":"GABAA receptor"},{"ns":0,"exists":"","*":"Glycine"},{"ns":0,"exists":"","*":"ICD-10"},{"ns":0,"exists":"","*":"International Standard Book Number"},{"ns":0,"exists":"","*":"International Standard Serial Number"},{"ns":0,"exists":"","*":"International Statistical Classification of Diseases and Related Health Problems"},{"ns":0,"exists":"","*":"MRI"},{"ns":0,"exists":"","*":"Missense mutation"},{"ns":0,"exists":"","*":"Neuronal ceroid lipofuscinosis"},{"ns":0,"exists":"","*":"OMIM"},{"ns":0,"exists":"","*":"Orphanet"},{"ns":0,"exists":"","*":"Partial seizure"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"Rare disease"},{"ns":0,"exists":"","*":"Sanger sequencing"},{"ns":0,"exists":"","*":"Sodium valproate"},{"ns":0,"exists":"","*":"Tonic\u2013clonic seizure"},{"ns":0,"exists":"","*":"\u0392 amyloid"}],"templates":[{"ns":10,"exists":"","*":"Template:Infobox medical condition (new)"},{"ns":10,"exists":"","*":"Template:Infobox"},{"ns":10,"exists":"","*":"Template:Template other"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Cite book"},{"ns":10,"exists":"","*":"Template:Cite web"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Medical resources"},{"ns":10,"exists":"","*":"Template:Hlist"},{"ns":10,"exists":"","*":"Template:Str find"},{"ns":828,"exists":"","*":"Module:Infobox"},{"ns":828,"exists":"","*":"Module:Navbar"},{"ns":828,"exists":"","*":"Module:InfoboxImage"},{"ns":828,"exists":"","*":"Module:String2"},{"ns":828,"exists":"","*":"Module:WikidataIB/sandbox"},{"ns":828,"exists":"","*":"Module:Complex date"},{"ns":828,"exists":"","*":"Module:I18n/complex date"},{"ns":828,"exists":"","*":"Module:Ordinal"},{"ns":828,"exists":"","*":"Module:Yesno"},{"ns":828,"exists":"","*":"Module:Roman"},{"ns":828,"exists":"","*":"Module:ISOdate"},{"ns":828,"exists":"","*":"Module:DateI18n"},{"ns":828,"exists":"","*":"Module:I18n/date"},{"ns":828,"exists":"","*":"Module:Calendar"},{"ns":828,"exists":"","*":"Module:I18n"},{"ns":828,"*":"Module:WikidataIB/i18n"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:List"},{"ns":828,"exists":"","*":"Module:TableTools"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:String"}],"images":["Autosomal_recessive_-_en.svg"],"externallinks":["http://preventiongenetics.com/print-test?id=1804","http://ghr.nlm.nih.gov/condition/northern-epilepsy","https://link.springer.com/article/10.1007/s100720070039","//doi.org/10.1007/s100720070039","//www.ncbi.nlm.nih.gov/pubmed/11073227","//doi.org/10.1016/j.bbadis.2006.05.006","//www.ncbi.nlm.nih.gov/pubmed/16828266","http://onlinelibrary.wiley.com/doi/10.1111/j.1750-3639.2000.tb00255.x/abstract","//doi.org/10.1111/j.1750-3639.2000.tb00255.x","//www.worldcat.org/issn/1750-3639","http://www.sciencedirect.com/science/article/pii/S0925443913000914#","//doi.org/10.1016/j.bbadis.2013.03.017","//www.ncbi.nlm.nih.gov/pubmed/23542453","https://omim.org/entry/610003","http://www.diseasesdatabase.com/ddb33514.htm","http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=1947"],"sections":[{"toclevel":1,"level":"2","line":"Characteristics","number":"1","index":"1","fromtitle":"Northern_epilepsy_syndrome","byteoffset":1912,"anchor":"Characteristics"},{"toclevel":2,"level":"3","line":"Early childhood","number":"1.1","index":"2","fromtitle":"Northern_epilepsy_syndrome","byteoffset":1935,"anchor":"Early_childhood"},{"toclevel":2,"level":"3","line":"Adolescence","number":"1.2","index":"3","fromtitle":"Northern_epilepsy_syndrome","byteoffset":2656,"anchor":"Adolescence"},{"toclevel":2,"level":"3","line":"Adulthood","number":"1.3","index":"4","fromtitle":"Northern_epilepsy_syndrome","byteoffset":3541,"anchor":"Adulthood"},{"toclevel":1,"level":"2","line":"Genetic causes","number":"2","index":"5","fromtitle":"Northern_epilepsy_syndrome","byteoffset":3906,"anchor":"Genetic_causes"},{"toclevel":1,"level":"2","line":"Pathophysiology","number":"3","index":"6","fromtitle":"Northern_epilepsy_syndrome","byteoffset":5127,"anchor":"Pathophysiology"},{"toclevel":1,"level":"2","line":"Diagnosis","number":"4","index":"7","fromtitle":"Northern_epilepsy_syndrome","byteoffset":5743,"anchor":"Diagnosis"},{"toclevel":1,"level":"2","line":"Treatment","number":"5","index":"8","fromtitle":"Northern_epilepsy_syndrome","byteoffset":6444,"anchor":"Treatment"},{"toclevel":1,"level":"2","line":"Prognosis","number":"6","index":"9","fromtitle":"Northern_epilepsy_syndrome","byteoffset":7214,"anchor":"Prognosis"},{"toclevel":1,"level":"2","line":"History","number":"7","index":"10","fromtitle":"Northern_epilepsy_syndrome","byteoffset":7845,"anchor":"History"},{"toclevel":1,"level":"2","line":"See also","number":"8","index":"11","fromtitle":"Northern_epilepsy_syndrome","byteoffset":8951,"anchor":"See_also"},{"toclevel":1,"level":"2","line":"References","number":"9","index":"12","fromtitle":"Northern_epilepsy_syndrome","byteoffset":9028,"anchor":"References"},{"toclevel":1,"level":"2","line":"External links","number":"10","index":"13","fromtitle":"Northern_epilepsy_syndrome","byteoffset":9055,"anchor":"External_links"}],"parsewarnings":[],"displaytitle":"Northern epilepsy syndrome","iwlinks":[{"prefix":"d","url":"https://www.wikidata.org/wiki/Q7059204","*":"d:Q7059204"}],"properties":[{"name":"wikibase_item","*":"Q7059204"}]}}